account
search
search

Saab to market NonLethal Technologies products in Europe

Saab's Swiss subsidiary has signed a marketing deal for crowd-control products with a U.S. company.
By Richard Tomkins   |   Updated June 19, 2014 at 9:19 AM
| License Photo
LINKOPING, Sweden, June 19 (UPI) -- A Swiss subsidiary of Saab is to market non-lethal crowd-control products in Europe made by NonLethal Technologies of the United States.

Covered under the long-term exclusive cooperative agreement between Saab Bofors Dynamics Switzerland Ltd and NLT are the U.S. company's IronFistTM and Cobra40TM less-lethal weapon systems, which include 37mm and 40mm non-lethal pellet cartridges, foam projectiles, ballistic bags and muzzle blast cartridges.

"NLT and SBDS will make a world-class team given both companies' prominent positions in their markets with superior products," said Stephan Kocher, chief executive officer of SBDS. "The companies share common core values and market strategies. They are fast, innovative, quality producers well-known in their respective markets and willing to move quickly.

"We will benefit from each other through our complementary know-how, products and networks. I am convinced that this cooperation will be the start of another success story within our company."

SBDS designs, develops and produces mortar rounds, warheads and less-lethal products -- primarily in large calibers -- for the military, corrections and law enforcement.

"We look forward to this cooperative opportunity with the SBDS marketing team, to introduce our less-lethal weapons and munitions to the European defense, correctional and law enforcement communities," said Scott Oberdick, president of NLT. "The SBDS experience and reputation for high-quality, high-performance weapons and munitions, along with the strength of its management and support services within the defense industry, assures us of a strong teaming effort in Europe."

Related UPI Stories
© 2014 United Press International, Inc. All Rights Reserved. Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent.
x
Feedback